ExploreWatchlistsPricing
  1. JP-listed companies
  2. MEDINET Co., Ltd.
  3. Financials
  4. EBITDA margin (%)

MEDINET Co., Ltd. (2370)

Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Sep 30, 2025-165.9+0.35%
Sep 30, 2024-165.3-17.34%
Sep 30, 2023-200+3.24%
Sep 30, 2022-193.7+36.97%
Sep 30, 2021-141.4+43.58%
Sep 30, 2020-98.5+30.16%
Sep 30, 2019-75.7-69.88%
Sep 30, 2018-251.2+188.97%
Sep 30, 2017-86.9+25.33%
Sep 30, 2016-69.4-20.65%
Sep 30, 2015-87.4+33.02%
Sep 30, 2014-65.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat